Clinical trial
"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending…
NCT00114933 · Arribas, Jose R., M.D., Other · Completed
Key facts
| NCT number | NCT00114933 |
|---|---|
| Title | "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects |
| Official title | Phase III-IV, Comparative, Randomized, Open-Label, Study to Evaluate Safety and Efficacy of Suspending Nucleosides From a Triple-Drug Therapy Based on Lopinavir/Ritonavir Versus Continuing Triple-Drug Therapy in HIV-Infected Subjects With Undetectable Plasma HIV Viremia for Six Months |
| Lead sponsor | Arribas, Jose R., M.D., Other |
| Collaborators | Pulido, Federico, M.D. Abbott Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | Stopping nucleosides and continuing lopinavir/ritonavir monotherapy |
| Enrollment | 200 |
| Start date | Jan 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Jun 21, 2005 |
| Last update posted | Mar 21, 2008 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: